IRB-CRF – (11/13) Page 1 of 3
Instructions: Federal regulation requires that research protocols be reviewed by the IRB on a regular basis for continued
approval. This form must be submitted one month prior to the IRB approval expiration date. No research may be
conducted passed the expiration date unless the study has been reviewed and renewed by the IRB.
Section I General Study Information
Name of Primary Investigator (PI):
Name of Co-Investigator (if applicable):
Section II Research Status
How many participants have enrolled in the study to date?
How many participants was your study approved to enroll?
How many participants do you intend to enroll in the future?
How many participants have withdrawn from the study to date?
Please describe the reasons for withdrawal from the study, if known:
Have any unanticipated problems or adverse events occurred during the duration of the approval period?
If yes, please summarize the events:
If yes, did you promptly report these events to the IRB via the Adverse Event Report Form?
If no, you must submit an Adverse Event Report Form to the IRB along with the Continuing Review Form.
IRB CONTINUING REVIEW FORM